Evaluation of a cure process during alarm treatment for nocturnal enuresis
✍ Scribed by Kazunari Ikeda; Aito Koga; Satoru Minami
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 187 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0021-9762
No coin nor oath required. For personal study only.
✦ Synopsis
Using a treatment package featuring the urine alarm, this study evaluated a treatment process for nocturnal enuresis. Children who received the training were classified into treatment successes (N ϭ 38) and nonsuccesses (N ϭ 19) according to a criterion (3-week continence). Their daily results were analyzed with four categories: dry with sleep (DS), dry with spontaneous awakening (DA), wet with spontaneous or alarm-forced awakening (WA), and wet with sleep (WS). In a trend analysis, an increase of DA over the treatment process was prominent for successes compared to nonsuccesses. Entering WA to a discriminant analysis, 86% of children were correctly classified into the two groups. The findings that awakening categories well distinguished successes from nonsuccesses provide support for an active avoidance model explaining the efficacy of urine-alarm treatment for nocturnal enuresis.
📜 SIMILAR VOLUMES
## Abstract This paper describes 5 phases of full‐scale testing at the City of Los Angeles Hyperion Treatment Plant (HTP) for producing Class A biosolids (U.S. EPA Part 503 Biosolids Rule) by thermophilic anaerobic digestion. Phases I and II were tests with a two‐stage continuous‐batch process in a
## Abstract Advanced oxidation processes (AOPs) are aggressive chemical oxidation techniques that are characterized by the formation of hydroxyl radicals. This treatability study evaluated the performance of the following AOPs for treating cyanide‐contaminated wastewater from an engine manufacturin
## Abstract Sertraline and paroxetine are frequently prescribed SSRIs for long‐term treatment of major depression. Nevertheless, continuous follow‐ups of drug concentrations prevailing in patients during the whole treatment period are not available. Hence, in a large phase IV clinical trial, a tota